Literature DB >> 10397736

Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia.

M T Dorak1, T Lawson, H K Machulla, C Darke, K I Mills, A K Burnett.   

Abstract

Genetic and environmental factors play an interactive role in the development of childhood acute lymphoblastic leukemia (ALL). Since the demonstration of a major histocompatibility complex (MHC) influence on mouse leukemia in 1964, an HLA association has been considered as a possible genetic risk factor. Despite extensive efforts, however, no strong evidence comparable to the H-2(k) influence on mouse leukemia has been shown. The number of negative serological studies resulted in a loss of interest and consequently, no molecular HLA-DR association study has been published to date. We reconsidered the HLA-DR association in childhood ALL in 114 patients from a single center and 325 local newborn controls by polymerase chain reaction (PCR) analysis of the HLA-DRB1/3/4/5 loci. With conventional analysis, there was a moderate allelic association with the most common allele in the HLA-DR53 group, HLA-DRB1*04, in the whole group that was stronger in males (P =.0005, odds ratio = 2.9). When the other expressed HLA-DRB loci were examined, homozygosity for HLA-DRB4*01, encoding the HLA-DR53 specificity, was increased in patients (21.1% v 8.3%; odds ratio = 2.9, P =.0005). Consideration of gender showed that all of these associations were reflections of a male-specific increase in homozygosity for HLA-DRB4*01 (32.8% v 4. 0%; odds ratio = 11.7, 95% confidence interval [CI] = 4.9 to 28.0; P = 3 x 10(-8)). This highly significant result provided the long-suspected evidence for the HLA-DR influence on the development of childhood ALL while confirming the recessive nature of the MHC influence on human leukemogenesis as in experimental models. The cross-reactivity between HLA-DR53 and H-2Ek, extensive mimicry of the immunodominant epitope of HLA-DR53 by several carcinogenic viruses, and the extra amount of DNA in the vicinity of the HLA-DRB4 gene argue for the case that HLA-DRB4*01 may be one of the genetic risk factors for childhood ALL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397736

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.

Authors:  Jason R Cantor; Tae Hyeon Yoo; Aakanksha Dixit; Brent L Iverson; Thomas G Forsthuber; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-05       Impact factor: 11.205

2.  Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL).

Authors:  Elias Orouji; Jalil Tavakkol Afshari; Zahra Badiee; Abbas Shirdel; Afrouz Alipour
Journal:  Int J Hematol       Date:  2012-03-21       Impact factor: 2.490

3.  An immunogenetic basis for the high prevalence of urogenital cancer in a free-ranging population of California sea lions (Zalophus californianus).

Authors:  Lizabeth Bowen; Brian M Aldridge; Robert Delong; Sharon Melin; Elizabeth L Buckles; Frances Gulland; Linda J Lowenstine; Jeffrey L Stott; Michael L Johnson
Journal:  Immunogenetics       Date:  2005-01-14       Impact factor: 2.846

Review 4.  Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Atsushi Manabe; Shuki Mizutani
Journal:  Int J Hematol       Date:  2012-12-13       Impact factor: 2.490

5.  Human leukocyte antigen-DRB1 polymorphism in childhood acute lymphoblastic leukemia.

Authors:  Mervat M El Ansary; Lamiaa A Mohammed; Tamer H Hassan; Ahmed Baraka; Alshymaa A Ahmed
Journal:  Mol Clin Oncol       Date:  2014-11-25

6.  Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk.

Authors:  Chenan Zhang; Joseph L Wiemels; Helen M Hansen; Julio Gonzalez-Maya; Alyson A Endicott; Adam J de Smith; Ivan V Smirnov; John S Witte; Libby M Morimoto; Catherine Metayer; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

7.  HLA complex-linked heat shock protein genes and childhood acute lymphoblastic leukemia susceptibility.

Authors:  Esma Ucisik-Akkaya; Charronne F Davis; Clara Gorodezky; Carmen Alaez; M Tevfik Dorak
Journal:  Cell Stress Chaperones       Date:  2009-12-09       Impact factor: 3.667

8.  A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia.

Authors:  Kevin Y Urayama; Patricia A Buffler; Emily R Gallagher; Julie M Ayoob; Xiaomei Ma
Journal:  Int J Epidemiol       Date:  2010-01-27       Impact factor: 7.196

9.  Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia.

Authors:  Kuan-Po Huang; Andrew J Chase; Nicholas C P Cross; Andrea Reiter; Tzu-Ying Li; Tso-Fu Wang; Sung-Chao Chu; Xuan-Yin Lu; Chi-Cheng Li; Ruey-Ho Kao
Journal:  Int J Hematol       Date:  2008-07-02       Impact factor: 2.490

10.  HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Catherine Metayer; Xiaomei Ma; Steve Selvin; Lisa F Barcellos; Joseph L Wiemels; John K Wiencke; Malcolm Taylor; Paul Brennan; Gary V Dahl; Priscilla Moonsamy; Henry A Erlich; Elizabeth Trachtenberg; Patricia A Buffler
Journal:  Blood       Date:  2012-08-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.